Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Salek

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|October 23, 2020
Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented OutcomesA Y Finlay, P V Chernyshov, L Tomas Aragones, et al.
Lancet (London, England)|July 20, 1991
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisJ M Sowden, J Berth-Jones, J S Ross, et al.
Health and Quality of Life Outcomes|May 10, 2013
The development and validation of the major life changing decision profile (MLCDP)Zaheer U Bhatti, Sam S Salek, Charlotte E Bolton, et al.
The British Journal of Dermatology|October 1, 1993
Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trialM S Salek, A Y Finlay, D K Luscombe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 23, 2021
Quality of life assessment in core outcome sets: A position statement of the EADV Task Force on Quality of Life and Patient Oriented OutcomesP V Chernyshov, A W M Evers, A Bewley, et al.
Journal of the American Academy of Dermatology|June 1, 1996
Cyclosporine in severe childhood atopic dermatitis: a multicenter studyJ Berth-Jones, A Y Finlay, I Zaki, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2022
Further insights into the wider impact of childhood atopic dermatitis - Comment on "Burden of childhood atopic dermatitis on parents: Fathers' and mothers' respective feelings" by Mahé et alPavel V Chernyshov, Lucia Tomas-Aragones, Dennis Linder, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 15, 2017
Quimp (quality of life impairment): an addition to the quality of life lexiconP V Chernyshov, M D Linder, N Pustišek, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2016
Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of LifeA Y Finlay, M S Salek, D Abeni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 21, 2017
Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instrumentsF Sampogna, A Y Finlay, S S Salek, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Journal of the European Academy of Dermatology and Venereology : JEADV|October 23, 2020
Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented OutcomesA Y Finlay, P V Chernyshov, L Tomas Aragones, et al.
Lancet (London, England)|July 20, 1991
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisJ M Sowden, J Berth-Jones, J S Ross, et al.
Health and Quality of Life Outcomes|May 10, 2013
The development and validation of the major life changing decision profile (MLCDP)Zaheer U Bhatti, Sam S Salek, Charlotte E Bolton, et al.
The British Journal of Dermatology|October 1, 1993
Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trialM S Salek, A Y Finlay, D K Luscombe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 23, 2021
Quality of life assessment in core outcome sets: A position statement of the EADV Task Force on Quality of Life and Patient Oriented OutcomesP V Chernyshov, A W M Evers, A Bewley, et al.
Journal of the American Academy of Dermatology|June 1, 1996
Cyclosporine in severe childhood atopic dermatitis: a multicenter studyJ Berth-Jones, A Y Finlay, I Zaki, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2022
Further insights into the wider impact of childhood atopic dermatitis - Comment on "Burden of childhood atopic dermatitis on parents: Fathers' and mothers' respective feelings" by Mahé et alPavel V Chernyshov, Lucia Tomas-Aragones, Dennis Linder, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 15, 2017
Quimp (quality of life impairment): an addition to the quality of life lexiconP V Chernyshov, M D Linder, N Pustišek, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2016
Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of LifeA Y Finlay, M S Salek, D Abeni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 21, 2017
Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instrumentsF Sampogna, A Y Finlay, S S Salek, et al.
Pageof 12